| ISMOX | PEMGX | ISMOX / PEMGX | |
| Total Expense Ratio | 1.08 | 0.90 | 120% |
| Annual Report Gross Expense Ratio | 1.32 | 0.90 | 147% |
| Fund Existence | 25 years | 21 years | - |
| Gain YTD | 8.424 | -5.745 | -147% |
| Front Load | N/A | 6% | - |
| Min. Initial Investment | 0 | 1000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 983M | 23.9B | 4% |
| Annual Yield % from dividends | 0.00 | 0.00 | - |
| Returns for 1 year | -7.21 | -13.67 | 53% |
| Returns for 3 years | 22.77 | 13.08 | 174% |
| Returns for 5 years | -78.79 | -3.98 | 1,981% |
| Returns for 10 years | -67.60 | 86.59 | -78% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| AHSCX | 15.54 | 0.37 | +2.44% |
| Alger Health Sciences C | |||
| RTRRX | 8.36 | 0.17 | +2.08% |
| Royce Small-Cap Total Return R | |||
| PNAIX | 77.81 | -0.19 | -0.24% |
| T. Rowe Price All-Cap Opportunities-I | |||
| FSTLX | 39.26 | -0.16 | -0.41% |
| Federated Hermes MDT Large Cap Value R6 | |||
| HSLSX | 50.81 | -0.38 | -0.74% |
| Hartford Small Cap Growth R4 | |||